(lp0
S"Integra to Acquire Derma Sciences for $204M Genetic Engineering & Biotechnology News  - Jan 11, 2017 Integra said the transaction will accelerate its advanced wound care strategy through the addition of the amniotic tissue-based products of Derma Sciences, a tissue regeneration company focused on advanced wound and burn care. Derma Sciences'&nbsp;...Derma Sciences to Be Acquired by Integra LifeSciences for $7.00 Per Share of ... - Business Wire Integra LifeSciences to Acquire Derma Sciences Inc. and Announces Preliminary ... - GlobeNewswire "
p1
aS'Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced ... Business Wire  - Jul 28, 2016 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces the signing of a definitive agreement to acquire BioD, LLC for an immediate transaction&nbsp;...Deal Could Cost Derma Sciences Inc.  $78 Million - Scibility Media$77.8M deal: Princeton tissue regeneration firm buys Tennessee company - Philadelphia Business Journal'
p2
aS'Integra LifeSciences Commences Previously Announced Cash Tender Offer to ... GlobeNewswire  - Jan 25, 2017 PLAINSBORO, N.J., Jan. 25, 2017  -- Integra LifeSciences Holdings Corporation  , a global leader in medical technology, announced today that its wholly-owned subsidiary, Integra Derma, Inc. ,&nbsp;...'
p3
aS"Derma Sciences Hit With Suits Over $204M Integra Buy Law360  - Feb 1, 2017 Law360, New York  -- Integra LifeSciences Holdings Corp.'s proposal to buy Derma Sciences Inc. is unfair to shareholders because it undervalues the company and unfairly rewards Derma Sciences executives, according to&nbsp;..."
p4
aS'Derma Sciences Announces Leadership and CEO Transition Business Wire  - Dec 21, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces that Stephen T. Wills, the Lead Director and a member of the Derma Sciences Board of&nbsp;...'
p5
aS'Derma Sciences Announces Results of Futility Analyses for Phase 3 Clinical ... Business Wire  - Nov 12, 2015 PRINCETON, N.J.----Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound and burn care, announces the termination of its Phase 3 clinical trials with aclerastide  for diabetic foot ulcer&nbsp;...'
p6
aS'Derma Sciences Hit With Another Suit Over Integra Buy Law360  - Feb 3, 2017 Law360, New York  -- Another Derma Sciences Inc. shareholder on Friday added his name to the list of proposed class actions filed against the company over Integra LifeSciences Holdings Corp.'
p7
aS"Derma Sciences closes $80m deal for BioD Mass Device - Aug 12, 2016 The buyout increased Derma Sciences' sales footprint by more than 300%, adding BioD's 235 independent sales reps and 7 direct reps to it own 63-member team of inside and independent reps."
p8
aS'Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New ... PR Newswire  - Jan 22, 2015 22, 2015 /PRNewswire/ -- Derma Sciences, Inc. , a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL and AMNIOMATRIX, amniotic allografts derived from placental tissues, have been added to&nbsp;...'
p9
aS"Derma Sciences'  CEO Stephen Wills on Q3 2016 Results - Earnings Call ... Seeking Alpha - Nov 10, 2016 Earlier this morning, Derma Sciences announced financial results for the 2016 third quarter. If you have not received this news release or if you would like to be added to the Company's distribution list, please call LHA in New York at 212-838-3777 and ..."
p10
a.